Close to 20 million new cancer cases were diagnosed worldwide in 2022, alongside 9.7 million cancer deaths. These figures, drawn from the World Health Organization’s global cancer observatory (GLOBOCAN), make cancer one of the leading causes of death in every region of the world. The burden is not shared equally: where you live, your sex, and your access to basic healthcare dramatically shape both your risk and your odds of survival.
The Most Common Cancers Worldwide
Lung cancer reclaimed the top spot in 2022 as the most frequently diagnosed cancer globally, responsible for nearly 2.5 million new cases, or about one in every eight diagnoses. Female breast cancer followed at 11.6% of all cases, then colorectal cancer at 9.6%, prostate cancer at 7.3%, and stomach cancer at 4.9%. Together, these five types account for roughly half of all cancer diagnoses on the planet.
The deadliest cancers largely mirror that list, with one notable exception. Lung cancer kills the most people by a wide margin: 1.8 million deaths annually. Colorectal cancer follows with 916,000 deaths, then liver cancer at 830,000, stomach cancer at 769,000, and breast cancer at 685,000. Liver cancer does not rank among the five most commonly diagnosed cancers, but its low survival rate pushes it into the top three for deaths.
Cancer Hits Men and Women Differently
Men die from cancer at substantially higher rates than women. Age-adjusted mortality for all cancers combined runs about 240 per 100,000 men compared to 162 per 100,000 women. That gap holds even after removing sex-specific cancers like prostate, ovarian, and cervical cancer from the calculation. The widest disparities appear in cancers of the lip, larynx, and esophagus, where men die at three to five times the rate of women, largely driven by higher rates of tobacco and alcohol use.
Only three cancer types kill women at higher rates than men: gallbladder cancer, cancers of the peritoneum (the lining of the abdomen), and anal cancer. These are relatively uncommon compared to the cancers that disproportionately affect men.
Roughly 40% of Cases Are Preventable
At least 40% of all cancer cases and nearly 50% of cancer deaths in adults over 30 can be traced to modifiable risk factors. That translates to more than 713,000 preventable cases and 262,000 preventable deaths each year in the United States alone. The single biggest driver is cigarette smoking, which accounts for about 23% of cancer cases in men and 16% in women. Globally, smoking is responsible for roughly one in every four cancer deaths, or 2.5 million deaths per year.
Beyond tobacco, the other major modifiable risks include excess body weight, alcohol consumption, physical inactivity, and certain infections like HPV and hepatitis B and C. These are not minor contributors. The fact that nearly half of cancer deaths tie back to avoidable exposures means prevention remains the most powerful tool available at a population level.
The Cervical Cancer Elimination Push
The WHO has set an ambitious target: eliminate cervical cancer as a public health problem by driving the incidence rate below 4 per 100,000 women in every country. The plan rests on three pillars, each with a specific 2030 target. First, 90% of girls should be fully vaccinated against HPV by age 15. Second, 70% of women should be screened with a high-performance test by age 35 and again by age 45. Third, 90% of women with precancerous changes should receive treatment, and 90% of those with invasive cancer should have access to proper management.
Meeting these “90-70-90” targets by 2030 would put the world on a path to elimination within the next century. Cervical cancer is one of the few cancers with a clear, achievable roadmap for near-total prevention.
A Stark Gap Between Rich and Poor Countries
Five-year survival for breast cancer illustrates the divide clearly: 88.6% in the United States and 87.4% in Brazil, compared to 59.8% in Algeria, 53.4% in South Africa, and 43.1% in Jordan. The pattern repeats across most cancer types. Richer countries consistently achieve higher survival because they have earlier detection, more treatment options, and greater capacity to deliver timely care.
The infrastructure gap is staggering. The United States operates more than 2,700 radiation machines. In Kenya, one of the two main referral hospitals has just two cobalt radiation machines for public patients, with wait times stretching to eight months. Private patients in Nairobi can access four newer machines, but only if they can pay out of pocket. Of the 52 cancer drugs on the international essential medicines list, only 18 are available in Kenya’s national formulary.
Cancer registries, which are essential for tracking the disease and planning responses, cover less than 10% of the world’s population. In Africa, that figure drops below 1%. Without reliable data, many countries cannot even measure the scope of their cancer burden, let alone address it.
Childhood Cancer Survival Depends on Geography
More than 80% of children diagnosed with cancer in high-income countries are cured. In most low- and middle-income countries, that number falls below 30%. The biology is the same. The difference is access to diagnosis, treatment, and supportive care. The WHO emphasizes that cure is possible for over 80% of childhood cancers when services are accessible, making the survival gap in poorer countries largely a failure of health systems rather than medicine.
Projected Cases by 2050
The global cancer burden is expected to grow sharply. Over 35 million new cases are predicted in 2050, a 77% increase from the 20 million cases recorded in 2022. Population aging is the primary driver, but rising rates of obesity, alcohol use, and air pollution in many regions will compound the problem. Low- and middle-income countries, many of which already lack basic cancer services, are expected to bear a disproportionate share of that increase.